AI Article Synopsis

  • Molecular breast imaging (MBI) is used to visualize cancer by tracking the uptake of Tc-sestamibi, and this study employed Monte Carlo simulations to estimate tumor diameters in focal breast lesions with a semi-automatic approach for clinical data.
  • Researchers simulated over 75,000 tumor profiles to establish a relationship between the full-width at half-maximum (FWHM) of the tumor's profile and its diameter, ultimately developing a linear formula to estimate diameter based on FWHM measurements.
  • The study showed that the methodology yielded mean error of only 0.2 mm, with 94% accuracy in tumor diameter estimation from patient data, indicating its potential effectiveness for clinical MBI applications.

Article Abstract

: Molecular breast imaging (MBI) is used clinically to visualize the uptake ofTc-sestamibi in breast cancers. Here, we use Monte Carlo simulations to develop a methodology to estimate tumor diameter in focal lesions and explore a semi-automatic implementation for clinical data.: A validated Monte Carlo simulation of the GE Discovery NM 750b was used to simulate >75,000 unique spherical/ellipsoidal tumor, normal breast, and image acquisition conditions. Subsets of this data were used to 1) characterize the dependence of the full-width at half-maximum (FWHM) of a tumor profile on tumor, normal breast, and acquisition conditions, 2) develop a methodology to estimate tumor diameters, and 3) quantify the diameter accuracy in a broad range of clinical conditions. Finally, the methodology was implemented in patient images and compared to diameter estimates from physician contours on MBI, mammography, and ultrasound imaging.: Tumor profile FWHM was determined be linearly dependent on tumor diameter but independent of other factors such as tumor shape, uptake, and distance from the detector. A linear regression was used to calculate tumor diameter from the FWHM estimated from a background-corrected profile across a tumor extracted from a median-filtered single-detector MBI image, i.e., diameter = 1.2 mm + 1.2 × FWHM, for FWHM ≥ 13 mm. Across a variety of simulated clinical conditions, the mean error of the methodology was 0.2 mm (accuracy), with >50% of cases estimated within 1-pixel width of the truth (precision). In patient images, the semi-automatic methodology provided the longest diameter in 94% (60/64) of cases. The estimated true diameters, for oval lesions with homogeneous uptake, differed by ± 5 mm from physician measurements.: This work demonstrates the feasibility of accurately quantifying tumor diameter in clinical MBI, and to our knowledge, is the first to explore its implementation and application in patient data.

Download full-text PDF

Source
http://dx.doi.org/10.1088/2057-1976/ac85f0DOI Listing

Publication Analysis

Top Keywords

tumor diameter
20
tumor
11
diameter
9
molecular breast
8
breast imaging
8
monte carlo
8
develop methodology
8
methodology estimate
8
estimate tumor
8
tumor normal
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!